课题基金 / 基金详情

Molecular Pathogenesis of Brain Damage and Gene Therapy in Genetic Leukodystrophy

Molecular Pathogenesis of Brain Damage and Gene Therapy in Genetic Leukodystrophy
遗传性脑白质营养不良脑损伤的分子发病机制和基因治疗
批准号:
11470176
负责人:
ETO Yoshikatsu
金额:
$9.54万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2001

项目摘要

项目成果

ETO Yoshikatsu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
1. Pathogenesis of Leukodystrophy in Globoide Cell Leukodystrophy and Other1) Using animal model of Krabbe globoid cell leukodystrophy(GLD), we tried to identified the cause of leukodytrophy in twitcher mice. The cause of neural cell damage might be caused by the influx of intracellular calcium in such mice which was demonstrated by patch cramp method. The increased intracellular calcium resulted in the activation of cellular protease and hense damage the neural cells.2) We studied the clinical phnotype and genotype in metachromatic leukodystrophy and also identified novel genotype in two cases with MLD. Furthermore, we demonstrated that the G99D mutation was neruological severe type and consisted of 50% of all genotype of Japanese MLD.3) Japanese patients with Sjogren Larrson syndrome shows particular genotype in Japanese.4) We studied the genotype identifications in Fabry disease which were L16H, A37V, W209X, 342QIVS-1-1 etc.2. Cell therapy and gene therapy in genetic leukodystrophyGene therapy and cell therapy were carried out using Twitcher mice and Sly Mice.1) Twitcher mice were treated with adenovirus vector which was administered into intraventricle, during fetal period. The number of globoid cells were decreased in treated animals after the administration of viral vetor. Simultaneously, the amount of psychosine was decreased in treated animals.2) Neural stem cells obtained fromhuman fetal brains were injected into Sly mice brain and the accumulated compounds in Sly mice were decreased. The data suggest that neural stem cells were effective for the treatment of The CNS involvement in these neurological mutants.3) Injection of mesenchymal stem cells into Sly mice showed decreased storage Materials and effective for neurological mice.
期刊论文(80)
专著(0)
科研奖励(0)
会议论文
Watabe K., Ohashi T., Sakamoto T., Kawazoe Y., Takeshima T., Oyanagi K., Inoue K., Eto Y., and Kim S.U.: "Rescue of lesioned adult rat spinal motoneurons by adenoviral gene transfer of glial cell line-derived neurotrophic factor."Journal of Neuroscience R
Watabe K.、Ohashi T.、Sakamoto T.、Kawazoe Y.、Takeshima T.、Oyanagi K.、Inoue K.、Eto Y. 和 Kim S.U.:“通过胶质细胞腺病毒基因转移来拯救受损的成年大鼠脊髓运动神经元
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oishi K., , Ida H., Eto Y., et al.: "Clinical and molecular of Japanese patients with neuronal・・・"Molecular Genetics and Metabolism. 66. 344-348 (1999)
Oishi K., , Ida H., Eto Y., et al.:“日本神经元患者的临床和分子......”分子遗传学和代谢 66. 344-348 (1999)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Kimura T, Ohashi T, Eto Y, et al.: "The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low-grade or superficial・・・"Cancer. 92. 2555-2561 (2001)
Kimura T、Ohashi T、Eto Y 等人:“FGFR3 基因致死性发育不良突变的发生率在低级别或浅表性癌症中较高……”癌症。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Watabe K, Ida H, Eto Y, et al: "Establishment and characterization of immortalized Schwann cells from murine model of Nieman-Pick disease C(spm/spm)"J Peripheral Nervous System. 6. 85-94 (2001)
Watabe K、Ida H、Eto Y 等人:“来自尼曼匹克病 C(spm/spm) 小鼠模型的永生化雪旺细胞的建立和表征”J 周围神经系统。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
39
    Anti-CD3 antibody induced immune tolerance to infused enzyme in enzyme replacement therapy for lysosomal storage disease
    • 批准号:
      21591333
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Immune tolerance induction in enzyme replacement therapy for lysosomal storage diseases
    • 批准号:
      19591223
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Development of novel therapy and elucidation of pathophysiology for genetic leukodystrophy
    • 批准号:
      14370252
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.28万
    • 财政年份:
      2002
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Prenatal Diagnosis of Ingenited Metabolic Disorders Using Maternal Blood
    • 批准号:
      11557061
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.1万
    • 财政年份:
      1999
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    海外基金